Regulatory Toxicology and Pharmacology

From WikiProjectMed
Jump to navigation Jump to search
Regulatory Toxicology and Pharmacology
DisciplineToxicology and pharmacology
LanguageEnglish
Edited by
  • Lesa L. Aylward
  • Martin van den Berg
Publication details
History1981–present
Publisher
Elsevier on behalf of the International Society of Toxicology & Pharmacology
FrequencyMonthly
3.271 (2021)
Standard abbreviations
ISO 4Regul. Toxicol. Pharmacol.
Indexing
CODENRTOPDW
ISSN0273-2300
LCCN81646304
OCLC no.485750423
Links

Regulatory Toxicology and Pharmacology is a monthly peer-reviewed scientific journal which covers legal aspects of toxicological and pharmacological regulations. It is published by Elsevier on behalf of the International Society of Regulatory Toxicology & Pharmacology. The current co-editors-in-chief are Lesa L. Aylward and Martin van den Berg.

Conflicts of interest

In 2002, a group of 45 academics wrote a letter accusing the journal of a concealed pro-industry bias, a possible lack of full and independent peer review, and a failure to disclose conflicts of interest, citing a case in which Gio Batta Gori, then-current editor-in-chief, was paid $30,000 by the Tobacco Institute to write an article later published in the journal dismissing the health risks of secondhand smoke.[1][2] The letter's coordinator later commented that the journal "reads like an industry trade publication, but it's masked as a peer-reviewed journal" and that it lacked any "credible peer-review process."[3] In response, the journal's publisher implemented a conflict of interest disclosure policy at the journal in January 2003, shortly before the correspondence was published.[1]

Abstracting and indexing

The journal is abstracted and indexed in EMBASE, EMBiology, and Scopus.

According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.031, ranking it 56th out of 87 journals in the category "Toxicology"[4] and 146th out of 254 journals in the category "Pharmacology & pharmacy".[5]

References

  1. ^ a b Axelson, O.; Balbus, J. M.; Cohen, G.; Davis, D.; Donnay, A.; Doolittle, R.; Duran, B. M.; Egilman, D.; Epstein, S. S.; Goldman, L.; Grandjean, P.; Hansen, E. S.; Heltne, P.; Huff, J.; Infante, P.; Jacobson, M. F.; Joshi, T. K.; Ladou, J.; Landrigan, P. J.; Lee, P. R.; Lockwood, A. H.; MacGregor, G.; Melnick, R.; Messing, K.; Needleman, H.; Ozonoff, D.; Ravanesi, B.; Richter, E. D.; Sass, J.; et al. (2003). Egilman, David (ed.). "Correspondence about Publication Ethics and Regulatory Toxicology and Pharmacology". International Journal of Occupational and Environmental Health. 9 (4): 286–391. doi:10.1179/oeh.2003.9.4.386. PMID 14664493.
  2. ^ Gori, Gio Batta; Mantel, Nathan (August 1991). "Mainstream and environmental tobacco smoke". Regulatory Toxicology and Pharmacology. 14 (1): 88–105. doi:10.1016/0273-2300(91)90054-Y. PMID 1947248.
  3. ^ Guterman, Lila (November 20, 2002). "Scientists Accuse Toxicology Journal of Industry Ties, Urge Disclosure of Conflicts of Interest". Chronicle of Higher Education.
  4. ^ "Journals Ranked by Impact: Toxicology". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.
  5. ^ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.

External links

Retrieved from "https://mdwiki.org/wiki/Regulatory_Toxicology_and_Pharmacology"